PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapy

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2426935122
Affiliations:
4
Authors:
18
Go to article
Institutions Authors Share
The Winship Cancer Institute of Emory University, United States of America (USA)
8.500000
 0.47
Hope Clinic, Emory Vaccine Center, United States of America (USA)
5.500000
 0.31
Center for Research and Technology Hellas (CERTH), Greece
3.000000
 0.17
Emory University, United States of America (USA)
1.000000
 0.06
Interested in Cardiovascular Medicine and Haematology?